Beijing Beilu Pharmaceutical Co., Ltd (300016.SZ)
CNY 5.99
(2.92%)
CNY 5.99
(2.92%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -100.43 Million CNY | -656.17% |
| 2022 | -13.28 Million CNY | -110.56% |
| 2021 | 125.79 Million CNY | -31.31% |
| 2020 | 183.12 Million CNY | -54.27% |
| 2019 | 400.47 Million CNY | 140.16% |
| 2018 | 166.75 Million CNY | 17.42% |
| 2017 | 142 Million CNY | 724.46% |
| 2016 | 17.22 Million CNY | -61.42% |
| 2015 | 44.64 Million CNY | -59.83% |
| 2014 | 111.13 Million CNY | 41.39% |
| 2013 | 78.6 Million CNY | 8.78% |
| 2012 | 72.26 Million CNY | 50.72% |
| 2011 | 47.94 Million CNY | 0.39% |
| 2010 | 47.76 Million CNY | 25.85% |
| 2009 | 37.94 Million CNY | 24.79% |
| 2008 | 30.41 Million CNY | -5.9% |
| 2007 | 32.31 Million CNY | 105.61% |
| 2006 | 15.71 Million CNY | 61.08% |
| 2005 | 9.75 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 15.21 Million CNY | -4.05% |
| 2024 Q3 | 2.3 Million CNY | 20.54% |
| 2024 Q1 | 15.86 Million CNY | 117.49% |
| 2023 Q3 | -11.84 Million CNY | -45.06% |
| 2023 Q4 | -90.7 Million CNY | -665.45% |
| 2023 FY | -100.43 Million CNY | -656.17% |
| 2023 Q1 | 10.28 Million CNY | 118.55% |
| 2023 Q2 | -8.16 Million CNY | -179.45% |
| 2022 Q3 | 4.1 Million CNY | 308.13% |
| 2022 FY | -13.28 Million CNY | -110.56% |
| 2022 Q2 | -1.97 Million CNY | -104.93% |
| 2022 Q4 | -55.42 Million CNY | -1449.82% |
| 2022 Q1 | 40.01 Million CNY | 360.71% |
| 2021 Q2 | 74.59 Million CNY | 41.74% |
| 2021 Q1 | 52.62 Million CNY | 514.67% |
| 2021 Q4 | -15.34 Million CNY | -210.22% |
| 2021 Q3 | 13.92 Million CNY | -81.33% |
| 2021 FY | 125.79 Million CNY | -31.31% |
| 2020 FY | 183.12 Million CNY | -54.27% |
| 2020 Q2 | 68.16 Million CNY | 119.14% |
| 2020 Q3 | 75.3 Million CNY | 10.48% |
| 2020 Q4 | 8.56 Million CNY | -88.63% |
| 2020 Q1 | 31.1 Million CNY | -84.81% |
| 2019 Q2 | 82.82 Million CNY | 74.15% |
| 2019 FY | 400.47 Million CNY | 140.16% |
| 2019 Q4 | 204.74 Million CNY | 213.33% |
| 2019 Q3 | 65.34 Million CNY | -21.1% |
| 2019 Q1 | 47.55 Million CNY | 167.95% |
| 2018 FY | 166.75 Million CNY | 17.42% |
| 2018 Q3 | 48.06 Million CNY | -28.03% |
| 2018 Q1 | 34.15 Million CNY | 44.25% |
| 2018 Q4 | 17.74 Million CNY | -63.07% |
| 2018 Q2 | 66.78 Million CNY | 95.55% |
| 2017 Q4 | 23.67 Million CNY | -35.31% |
| 2017 FY | 142 Million CNY | 724.46% |
| 2017 Q2 | 53.47 Million CNY | 89.22% |
| 2017 Q1 | 28.26 Million CNY | 137.46% |
| 2017 Q3 | 36.59 Million CNY | -31.57% |
| 2016 Q1 | 23.82 Million CNY | 146.76% |
| 2016 Q3 | 28.28 Million CNY | -29.06% |
| 2016 Q2 | 39.86 Million CNY | 67.32% |
| 2016 Q4 | -75.44 Million CNY | -366.77% |
| 2016 FY | 17.22 Million CNY | -61.42% |
| 2015 Q3 | 28.72 Million CNY | -29.64% |
| 2015 FY | 44.64 Million CNY | -59.83% |
| 2015 Q2 | 40.82 Million CNY | 56.69% |
| 2015 Q4 | -50.94 Million CNY | -277.38% |
| 2015 Q1 | 26.05 Million CNY | -39.29% |
| 2014 Q4 | 42.91 Million CNY | 102.92% |
| 2014 Q1 | 17.51 Million CNY | -17.84% |
| 2014 Q2 | 29.55 Million CNY | 68.7% |
| 2014 FY | 111.13 Million CNY | 41.39% |
| 2014 Q3 | 21.14 Million CNY | -28.45% |
| 2013 FY | 78.6 Million CNY | 8.78% |
| 2013 Q4 | 21.32 Million CNY | 15.66% |
| 2013 Q1 | 15.65 Million CNY | -23.3% |
| 2013 Q2 | 23.09 Million CNY | 47.52% |
| 2013 Q3 | 18.43 Million CNY | -20.17% |
| 2012 Q3 | 19.08 Million CNY | -14.54% |
| 2012 FY | 72.26 Million CNY | 50.72% |
| 2012 Q4 | 20.41 Million CNY | 6.98% |
| 2012 Q2 | 22.32 Million CNY | 113.78% |
| 2012 Q1 | 10.44 Million CNY | -19.26% |
| 2011 Q3 | 12.94 Million CNY | 5.77% |
| 2011 Q2 | 12.23 Million CNY | 24.6% |
| 2011 FY | 47.94 Million CNY | 0.39% |
| 2011 Q1 | 9.82 Million CNY | 15.36% |
| 2011 Q4 | 12.93 Million CNY | -0.08% |
| 2010 Q1 | 11.24 Million CNY | 54.52% |
| 2010 Q2 | 14.44 Million CNY | 28.48% |
| 2010 Q3 | 13.56 Million CNY | -6.09% |
| 2010 FY | 47.76 Million CNY | 25.85% |
| 2010 Q4 | 8.51 Million CNY | -37.21% |
| 2009 Q4 | 7.27 Million CNY | -29.57% |
| 2009 Q2 | 13.24 Million CNY | 88.74% |
| 2009 Q1 | 7.01 Million CNY | 59.24% |
| 2009 FY | 37.94 Million CNY | 24.79% |
| 2009 Q3 | 10.32 Million CNY | -22.03% |
| 2008 Q3 | 7.82 Million CNY | 0.0% |
| 2008 Q4 | 4.4 Million CNY | -43.69% |
| 2008 FY | 30.41 Million CNY | -5.9% |
| 2007 FY | 32.31 Million CNY | 105.61% |
| 2006 FY | 15.71 Million CNY | 61.08% |
| 2005 FY | 9.75 Million CNY | 0.0% |